Who To Contact
Baptist MD Anderson
Cancer Center
1301 Palm Avenue
Jacksonville, FL 32207
Poonam K. Neki, MBBS,DA, CCRP
Research Director
Baptist MD Anderson Clinical Trials
904.202.7468
poonam.neki@bmcjax.com
Clinical Trial ID: NCT05324501
PHASE 1 OPEN LABEL ASCENDING DOSE STUDY TO ASSESS THE FEASIBILITY AND SAFETY OF INTERMITTENT INFUSIONS OF MTX110 ADMINISTERED BY CONVECTION-ENHANCED DELIVERY (CED) AS A MONOTHERAPY OR IN COMBINATION WITH LOMUSTINE IN PATIENTS WITH RECURRENT GLIOBLASTOMA (rGBM) (MAGIC-G1 STUDY)
Status
Open
Conditions
Other
Phases
1
Age Group
Adult
Main Investiagtor
Cavaliere, Robert
Practice
CNS
Scope
National
Participating Institutions
Baptist MD Anderson Cancer Center
Nct ID Number
NCT05324501
Secondary Trial ID Number
MTX110-102
Keywords
Treatment